Precipio, Inc.
NASDAQ: PRPO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ilan Danieli
- Employees
- 54
- Headquarters
- New Haven, United States
- IPO year
- 2017
- Market cap
- $41.0M
- Website
- https://www.precipiodx.com
Loading PRPO…
Loading profile data…Frequently asked questions about PRPO
What does Precipio, Inc. (PRPO) do?
Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture media capable of simultaneou...
Where does PRPO trade?
Precipio, Inc. (PRPO) trades on the NASDAQ Capital Market.
What sector is PRPO in?
Precipio, Inc. (PRPO) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Precipio, Inc.?
Ilan Danieli is the chief executive officer of Precipio, Inc. (PRPO).
Where is Precipio, Inc. headquartered?
Precipio, Inc. is headquartered in United States.
Does PRPO pay a dividend?
Precipio, Inc. (PRPO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PRPO go public?
Precipio, Inc. (PRPO) completed its initial public offering in 2017.